Method for synthesizing adenosine triphosphate by using biological enzyme
The bioenzymatic synthesis of adenosine triphosphate (ATP) utilizes adenosine acid and diammonium acetyl phosphate as raw materials. Under the catalysis of adenosine kinase and nucleoside diphosphate kinase, the high cost and long cycle of existing production methods are solved, achieving efficient and environmentally friendly ATP production.
Patent Information
- Application Number
- CN202411321868.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-23
- Publication Date
- 2024-11-29
AI Technical Summary
Existing methods for producing adenosine triphosphate (ATP) suffer from high costs, long production cycles, and low yields, especially chemical synthesis and bio-fermentation methods, which are insufficient for large-scale production.
Using adenosine and diammonium acetyl phosphate as raw materials, adenosine triphosphate is synthesized via a bioenzymatic method under the catalysis of adenosine kinase and nucleoside diphosphate kinase. Biotransformation is carried out using genetically engineered bacteria. The reaction conditions are mild, the yield is high, and the pollution is low.
It achieves low-cost and high-efficiency production of adenosine triphosphate with a product concentration as high as 92.3 g/L. The reaction steps are simple, environmentally friendly, and suitable for industrial production.
Smart Images

Figure BDA0005054208100000031 
Figure HDA0005054208110000011 
Figure HDA0005054208110000012
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biochemical engineering, and in particular relates to the field of enzyme-catalyzed synthesis of adenosine triphosphate. Background Art
[0002] Adenosine triphosphate, or ATP, is a nucleotide that plays a key role in living organisms. It is also known as adenosine triphosphate disodium, adenosine triphosphate, etc. Chemical formula: C 10 H 16 N5O 13 P3 molecular weight: 507.18; alias adenosine triphosphate, adenosine triphosphate disodium, triphosphate glycoside, adenosine triphosphate, adenosine triphosphate, etc., composed of five elements: carbon, hydrogen, oxygen, nitrogen and phosphorus.
[0003] The structure of ATP can be abbreviated as AP~P~P, where A represents adenosine, P represents a phosphate group, ~ represents a high-energy phosphate bond, and - represents an ordinary chemical bond. The ATP molecule contains two high-energy phosphate bonds and one ordinary phosphate bond, which release a large amount of energy when broken. Energy storage and transfer: ATP is the most direct source of energy in organisms and is called the "molecular currency" of intracellular energy. It stores and transfers chemical energy to provide energy support for various life activities of cells. Participation in metabolic processes: ATP participates in the metabolic processes of fat, protein, sugar, nucleic acid and nucleotides in the body, and is an important coenzyme for these biochemical reactions. Cell repair and regeneration: In medicine, ATP can promote the repair and regeneration of various cells in the body, enhance cell metabolic activity, and has an auxiliary therapeutic effect on a variety of diseases.
[0004] ATP is widely used in clinic to treat various diseases caused by tissue damage and decreased cell enzyme activity, such as heart failure, myocarditis, myocardial infarction, cerebral arteriosclerosis, coronary arteriosclerosis, progressive muscular atrophy, acute and chronic hepatitis, cirrhosis and hearing impairment, etc. It can be administered by intramuscular or intravenous injection, and the specific dosage and usage should be determined according to the condition and doctor's advice.
[0005] There are many ways to produce adenosine triphosphate (ATP), mainly including chemical synthesis, biological fermentation, enzyme catalysis synthesis, etc. Among them, the chemical synthesis method mainly forms ATP by reacting raw materials such as phosphoric acid, adenine and 5-phosphate under high temperature conditions. This method can produce ATP in large quantities, but the production cost is high, and it requires expensive preparation processes and highly precise control to ensure that the reaction proceeds correctly. Therefore, chemical synthesis is generally not suitable for large-scale ATP production.
[0006] The bio-fermentation method uses specific microorganisms (such as yeast) to convert organic matter into ATP through the respiratory process. These microorganisms use ATP to store energy to meet their survival needs. The raw materials of the bio-fermentation method are simple, usually only sugars and other basic compounds are needed. In addition, this method is more ecologically sustainable and does not produce toxic waste, but the production cycle is long and the yield is relatively low, resulting in a significant increase in production costs. Liu Shanshan, Liu Hui, etc. used the Escherichia coli system to add the substrate adenosine and produce adenylic acid by fermentation, with a reaction conversion rate of 85% [Engineering Technology I, 2019]. The enzyme-catalyzed synthesis method uses the catalytic action of enzymes to promote specific chemical reactions to synthesize ATP. This method is carried out under mild conditions and can efficiently and specifically synthesize the target product. The enzyme-catalyzed synthesis method has the advantages of mild reaction conditions, few by-products, and high product purity.
[0007] Therefore, it is a good trend to synthesize ATP by biotransformation synthesis at present. However, in view of the shortcomings of the existing production technology, the present invention is proposed. Summary of the invention
[0008] To solve the above problems, the present invention provides a method for synthesizing adenosine triphosphate by bioenzyme, wherein adenosine triphosphate is obtained by reaction of adenylic acid and acetyl diammonium phosphate as raw materials under the catalysis of adenylate kinase and nucleoside diphosphate kinase. The raw materials required by the process are widely available, cheap, simple in reaction steps, high in yield, mild in reaction process, and less in pollution.
[0009] The method for synthesizing adenosine triphosphate by bioenzymatic method of the present invention comprises the following steps: using adenosine triphosphate and acetyl diammonium phosphate as raw materials, carrying out biotransformation under the action of phosphokinase genetic engineering bacteria to obtain adenosine triphosphate. The reaction equation is expressed as:
[0010]
[0011] Furthermore, in the above technical solution, Mg is added to the reaction system. 2+ Start the reaction.
[0012] Furthermore, in the above technical solution, the phosphokinase genetically engineered bacteria co-expresses two enzymes, adenylate kinase and nucleoside diphosphate kinase, in one bacterial cell, Escherichia coli (i.e., the genetically engineered bacteria is a dual enzyme system in one bacterial cell), and then the constructed phosphokinase genetically engineered bacteria are subjected to fed-batch high-density fermentation culture until the bacterial cell concentration OD 600 =12-16, add inducer IPTG and induce culture for 8-12h; collect by centrifugation to obtain wet cells of phosphokinase gene engineering bacteria.
[0013] Furthermore, in the above technical solution, the Escherichia coli is selected from DH5α, BL21 (DE3), JM109, and HB101. Recombinant Escherichia coli BL21 (DE3) is preferred.
[0014] Furthermore, in the above technical solution, the form of the phosphokinase includes but is not limited to enzyme solution, enzyme lyophilized powder, enzyme-containing cells, and various immobilized enzymes and immobilized enzyme cells, and can be in the form of unpurified crude enzyme, or in a partially purified or completely purified form.
[0015] Further, in the above technical solution, the adenylate kinase sequence SEQ ID NO.1 is as follows: ATGCGTATCATTCTGCTTGGCGCTCCGGGCGCGGGGAAAGGGACT CAGGCTCAGTTCATCATGGAGAAATATGGTATTCCGCAAATCTCCACTGGCGATATGCTGCGTGCTGCGGTCAAATCTGGCTCCGAGCTGGGTAAACAAGCAAAAGACATTATGGATGCTGGCAAACTGGTCACCGACGAACTGGTGATCGCGCTGGTTAAAGAGCGCATTGCTCAGGAAGACTGCCGTAATGGTTTCCTGTTGGACGGCTTCCCGCGTACCATTCCGCAGGCAGACGCGATGAAAGAAGCGGGCATCAATGTTGATTACGTTCTGGAATTCGACGTACCGGACGAACTG ATCGTTGACCGTATCGTCGGTCGCCGCGTTCATGCGCCGTCTGGTCGTGTTTATCACGTTAAATTCAATCCGCCGAAAGTAGAAGGCAAAGACGACGTTACCGGTGAAGAACTGACTACCCGTAAAGATGATCAGGAAGAGACCGTACGT AAACGTCTGGTTGAATACCATCAGATGACAGCACCGCTGATCGGCTACTACTCCAAAGAAGCAGAAGCGGGTAATACCAAATACGCGAAAGTTGACGGCACCAAGCCGGTTGCTGAAGTTCGCGCTGATCTGGAAAAAATCCTCGGCTAA
[0016] Further, in the above technical solution, the sequence of the nucleoside diphosphate kinase SEQ ID NO.2 is as follows: ATGGCTATTGAACGTACTTTTTCCATCATCAAACCGAACGCG GTAGCAAAAAACGTCATTGGTAATATCTTTGCGCGCTTTGAAGCTGCAGGGTTTCAAAATTGTTGGCACCAAAATGCTGCACCTGACCGTTGAACAGGCACGTGGCTTTTTATGCTGAACACGATGGAAAACCGTTCTTTGATGGTCTGGTTGAATTCATGACCTCTGGCCCGATCGTGGTTTCCGTGCTGGAAGGT GAAAACGCCGTTCAGCGTCACCGCGATCTGCTGGGCGCGACCAATCCGGCAAACGCACTGGCTGGTACTCTGCGCGCTGATTACGCTGACAGCCTGACCGAAAACGGTACCCACGGTTCTGATTCCGTCGAATCTGCCGCTCGCGAAATCGCTTATTTCTTTGGCGAAGGCGAAGTGTGCCCGCGCACCCGTTAA
[0017] Furthermore, in the above technical solution, the reaction is carried out at a temperature of 25-35°C and a pH of 6.0-8.0.
[0018] Furthermore, in the above technical solution, the reaction is carried out in purified water.
[0019] Furthermore, in the above technical solution, the concentration of adenylic acid is 60-80 g / L, the concentration of acetyl diammonium phosphate is 30-50 g / L, and the concentration of phosphokinase is 2-20 g / L.
[0020] Furthermore, in the above technical solution, the product concentration of adenosine triphosphate reaches 92.3 g / L.
[0021] Beneficial effects of the present invention
[0022] (1) The method for synthesizing adenosine triphosphate by bioenzyme of the present invention has simple reaction steps, and the bioconversion reaction is carried out with purified water as the buffer system, which is pollution-free and more environmentally friendly. (2) The method for synthesizing adenosine triphosphate by bioenzyme of the present invention uses acetyl diammonium phosphate, which is more inexpensive, as the phosphate donor, which greatly reduces the production cost.
[0023] (3) The present invention utilizes a dual enzyme system of adenylate kinase and nucleoside diphosphate kinase to biotransform and synthesize adenosine triphosphate, which greatly shortens the reaction steps, has high system conversion efficiency, high substrate reaction ratio, and greatly improves the product generation amount.
[0024] (4) This process uses adenosine and acetyl diammonium phosphate as substrates for biotransformation to synthesize the product adenosine triphosphate. It is low-cost, environmentally friendly, easy to operate and suitable for industrialization.
[0025] (5) The method of synthesizing adenosine triphosphate by a bioenzymatic method of the present invention has a product adenosine triphosphate product concentration of 92.3 g / L. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] Figure 1 It is the temperature optimization reaction diagram in Example 3;
[0027] Figure 2 It is the pH optimization reaction diagram in Example 4;
[0028] Figure 3 The optimum substrate molar ratio optimization diagram in Example 5;
[0029] Figure 4 This is the HPLC detection chart in the reaction system in Example 6. Specific embodiments
[0030] Example 1 Construction of genetically engineered bacteria expressing adenylate kinase and nucleoside diphosphate kinase
[0031] Using primers adk-FW: cagcaaatgggtcgcggatccATGCGTATCATTCTGC TTGGC and adk-RS: ctcgagtgcggccgcaagcttTTAGCCGAGGATTTTTTC CAGA, PCR amplification was performed with the Escherichia coli BL21 genome as a template to obtain the adk target fragment (nucleotide sequence as SEQ ID NO.1).
[0032] Using primers ndk-FW: cagcaaatgggtcgcggatccATGGCTATTGAACGT ACTTTTTCCA and ndk-RS: ctcgagtgcggccgcaagcttTTAACGGGTGCGC GGGCA, PCR amplification was performed with the Escherichia coli BL21 genome as a template to obtain the ndk target fragment (nucleotide sequence as SEQ ID NO.2).
[0033] PCR amplification conditions: pre-denaturation at 98°C for 5 min; denaturation at 95°C for 30 s; annealing at 55°C for 30 s; extension at 72°C for 1 min; set the cycle to 29 times; re-extension at 72°C for 10 min; and finally insulation at 16°C.
[0034] PCR amplification system: 5×PS buffer 20 μL, dNTP 10 μL, upstream / downstream primers (10 μmol·L -1 )1μL, template 2μL, enzyme 1μL, water 66μL. Use restriction endonucleases HindⅢ and BamHI to cut PET28a plasmid. Use ligase to connect the amplified adk and ndk gene fragments with PET28a plasmid, transform Escherichia coli DH5α, apply LB plates to screen for positive clones, extract plasmids for gene sequencing verification, and obtain recombinant plasmid PET28a-adk-ndk.
[0035] Construction of recombinant E. coli strain OE_adk-ndk. The recombinant plasmid PET28a-adk-ndk obtained in the above steps was transformed into the E. coli strain BL21, and the positive clone recombinant E. coli strain OE_adk-ndk was obtained by coating LB plates for screening.
[0036] Example 2 Preparation of adenylate kinase and nucleoside diphosphate kinase
[0037] The phosphokinase engineered bacteria in the glycerol tube were streaked onto the LB solid plate, and the monoclonal colonies were picked and streaked again to obtain the corresponding enzyme engineered bacteria. The Escherichia coli strain was picked and inoculated into the LB liquid culture medium, and cultured at 37°C and 200rpm for 6h. The activated bacterial solution was transferred to the secondary culture medium at a 2% inoculation volume, and first cultured at 37°C and 200rpm until the bacterial concentration OD 600 =0.6, and then inoculated into a 4L fermenter at a 10% inoculation amount, and the bacterial concentration OD 600 =16, the inducer IPTG was added, and after 8h of induction culture, 234g of wet bacteria were collected by centrifugation.
[0038] Example 3 Temperature Optimization Reaction
[0039] According to the substrate ratio, accurately weigh 2g of adenylic acid, 1.81g of diammonium acetylphosphate, and 0.165g of magnesium chloride, add 1g of enzyme, and dilute to 30mL with purified water. React at 20, 30, 40, 50, and 60°C for 96-120h, and detect the amount of adenosine triphosphate produced by high-performance liquid chromatography. Finally, it was determined that at a reaction temperature of 30°C, the amount of adenosine arabinoside produced was better ( Figure 1 ), the amount of ATP produced reached 74 g / L at 7 h, and the substrate molar conversion rate was 76%.
[0040] Example 4 pH Optimization Reaction
[0041] Reaction system and reaction conditions: The reaction system includes 2g of adenylic acid, 1.81g of acetyl diammonium phosphate, 0.165g of magnesium chloride, and 1g of enzyme, and is adjusted to pH = 4.0, 5.0, 6.0, 7.0, and 8.0. After that, the purified water is diluted to 30mL, and the reaction is carried out in a 30°C water bath for 7h. During the reaction, samples are taken for HPLC detection to monitor the reaction progress. According to the analysis of the HPLC results, the reaction effect is significant when the initial pH of the reaction is 7.0. When the reaction is carried out for 7h, the amount of product adenosine triphosphate produced reaches 80g / L ( Figure 2 ).
[0042] Example 5 Optimization of the optimal substrate molar ratio
[0043] Based on the above reaction conditions, the molar ratio of the two substrates was adjusted and the conversion reaction was carried out for 96 h. The product content was determined and the substrate conversion rate was calculated ( Figure 3 ), the results showed that when the molar ratio of adenylate / acetyl diammonium phosphate was in the range of 0.1-1.0, the conversion rate of uridine arabinoside increased rapidly with the increase of substrate ratio, and the conversion rate did not change significantly after it was greater than 0.5. Therefore, the conversion reaction efficiency was highest when the substrate molar ratio was around 0.5.
[0044] Example 63L Amplification Reaction
[0045] According to the substrate ratio, 200 g of adenylic acid, 181 g of diammonium acetylphosphate, and 16.5 g of magnesium chloride were accurately weighed, pH was adjusted to 7.0 with alkali, 100 g of enzyme was added in proportion, and the volume was adjusted to 3 L with purified water.
[0046] The reaction was carried out at 30°C for 96-120 hours, and the amount of adenosine triphosphate generated was detected by high performance liquid chromatography ( Figure 4 ). The final measurement reaction lasted for 100 hours, and the highest ATP concentration was 86.7 g / L, and the substrate molar conversion rate could reach 89%.
[0047] Example 77L Amplification Reaction
[0048] According to the substrate ratio, 467 g of adenylic acid, 422 g of diammonium acetylphosphate, and 38.5 g of magnesium chloride were accurately weighed, pH was adjusted to 7.0 with alkali, 233 g of enzyme was added in proportion, and the volume was adjusted to 7 L with purified water.
[0049] The reaction was carried out at 30°C for 96-120 hours, and the amount of ATP produced was detected by high performance liquid chromatography. Finally, the reaction was carried out for 100 hours, and the highest ATP concentration was 92.3 g / L, and the substrate molar conversion rate could reach 95%.
[0050] The above embodiments describe the basic principles, main features and advantages of the present invention. Those skilled in the art should understand that the present invention is not limited by the above embodiments, and the above embodiments and the description are only used to explain the principles of the present invention. Without departing from the scope of the principles of the present invention, the present invention may have various changes and improvements, and these changes and improvements all fall within the scope of protection of the present invention.
Claims
1. A method for synthesizing adenosine triphosphate by biological enzymes, characterized in that: The method comprises the following steps: taking adenylic acid and acetyl diammonium phosphate as raw materials, carrying out biotransformation under the catalysis of phosphokinase gene engineering bacteria to prepare adenosine triphosphate.
2. The method for synthesizing adenosine triphosphate by bioenzyme according to claim 1, characterized in that: Add Mg to the reaction system 2 + Start the reaction.
3. The method for synthesizing adenosine triphosphate by bioenzyme according to claim 1, characterized in that: The phosphokinase gene engineering bacteria co-expresses two enzymes, adenylate kinase and nucleoside diphosphate kinase, in one bacterial cell, Escherichia coli, and then the constructed phosphokinase gene engineering bacteria are subjected to fed-batch high-density fermentation culture until the bacterial concentration OD 600 =12-16, add inducer IPTG and induce culture for 8-12h; collect by centrifugation to obtain wet cells of phosphokinase gene engineering bacteria.
4. The method for synthesizing adenosine triphosphate by bioenzyme according to claim 3, characterized in that: The Escherichia coli is selected from DH5α, BL21 (DE3), JM109, and HB101.
5. The method for synthesizing adenosine triphosphate by bioenzyme according to claim 3, characterized in that: The adenosine kinase sequence is the nucleotide sequence shown in SEQ ID NO.
1.
6. The method for synthesizing adenosine triphosphate by bioenzyme according to claim 3, characterized in that: The nucleoside diphosphate kinase sequence is the nucleotide sequence shown in SEQ ID NO.
2.
7. The method for synthesizing adenosine triphosphate by bioenzyme according to claim 1, characterized in that: The reaction is carried out at a temperature of 25-35°C and a pH of 6.0-8.
0.
8. The method for synthesizing adenosine triphosphate by bioenzyme according to claim 1, characterized in that: The reaction was carried out in pure water.
9. The method for synthesizing adenosine triphosphate by bioenzyme according to claim 1, characterized in that: The concentration of adenylic acid is 60-80 g / L, the concentration of acetyl diammonium phosphate is 30-50 g / L, and the concentration of phosphokinase is 2-20 g / L.
Citation Information
Cited By
Adenosine kinase mutant with double-enzyme activity and application of adenosine kinase mutant
CN121227661A
